Pernille Ravn

2009

Lymphangioleiomyomatosis in a patient with tuberous sclerosis and dysregulated diabetes mellitus

Mikkelsen, C. S., Mikkelsen, D. B., Madsen, H. D., Andersen, P. E., Ravn, P. & Bygum, A., 1. jan. 2009, I: Acta Dermato-Venereologica. 89, 2, s. 218-9 1 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2007

Medicinsk behandling af polycystisk ovariesyndrom (PCOS)

Ravn, P., 2007, I: Rationrl Farmakoterapi. 8

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Postmenopausal endometriosis

Oxholm, D., Knudsen, U. B., Kryger-Baggesen, N. & Ravn, P., 4. sep. 2007, I: Acta Obstetricia et Gynecologica Scandinavica. s. 1-7 6 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2006

Pulsed Estrogen Therapy improves postmenopausal quality of life: a 2-year placebo-controlled study

Nielsen, T. F., Ravn, P., Pitkin, J. & Christiansen, C., 20. jan. 2006, I: Maturitas. 53, 2, s. 184-190

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

What can be learned from the levormeloxifene experience?

Ravn, P., Faurschou Nielsen, T. & Christiansen, C., 2006, I: Acta Obstetricia et Gynecologica Scandinavica. 85, 2, s. 135-142

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2005

An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion

Ravn, P., Rasmussen, A., Knudsen, U. B. & Kristiansen, F. V., nov. 2005, I: Acta Obstetricia et Gynecologica Scandinavica. 84, 11, s. 1098-102 5 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis

Warming, L., Ravn, P. & Christiansen, C., 14. feb. 2005, I: Maturitas. 50, 2, s. 78-85 8 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2004

Changes in bone density and turnover after alendronate or estrogen withdrawal.

Wasnich, R. D., Bagger, Y. Z., Hosking, D. J., McClung, M. R., Wu, M., Mantz, A. M., Yates, J. J., Ross, P. D., Alexandersen, P., Ravn, P., Christiansen, C. & Santora, A. C., 2004, I: Menopause . 11, 6 Pt 1, s. 622-30 8 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

High frequency of congenital thrombophilia in women with pathological pregnancies?

Rasmussen, A. & Ravn, P., 1. sep. 2004, I: Acta Obstetricia et Gynecologica Scandinavica. 83, 9, s. 808-17 9 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study

McClung, M. R., Wasnich, R. D., Hosking, D. J., Christiansen, C., Ravn, P., Wu, M., Mantz, A. M., Yates, J., Ross, P. D. & Santora, II, A. C., 1. okt. 2004, I: The Journal of Clinical Endocrinology & Metabolism. 89, 10, s. 4879-4885

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study.

Nielsen, T. F., Ravn, P., Bagger, Y. Z., Warming, L. & Christiansen, C., 1. feb. 2004, I: Osteoporosis International. 15, 2, s. 168-74 6 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.

Warming, L., Ravn, P., Nielsen, T. & Christiansen, C., 1. mar. 2004, I: Climacteric. 7, 1, s. 103-11 8 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy

Ravn, P., Warming, L., Christgau, S. & Christiansen, C., 1. nov. 2004, I: Bone. 35, 5, s. 1216-21 5 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women

Warming, L., Ravn, P., Spielman, D., Delmas, P. & Christiansen, C., 2004, I: Menopause . 11, 3, s. 337-42 5 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study

Bagger, Y. Z., Tankó, L. B., Alexandersen, P., Hansen, H. B., Møllgaard, A., Ravn, P., Qvist, P., Kanis, J. A. & Christiansen, C., 1. apr. 2004, I: Bone. 34, 4, s. 728-35 7 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2003

Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal

Bagger, Y. Z., Tankó, L. B., Alexandersen, P., Ravn, P. & Christiansen, C., sep. 2003, I: Bone. 33, 3, s. 301-7 7 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Biochemical markers for prediction of 4-year response in bone mass during bisphosphonate treatment for prevention of postmenopausal osteoporosis

Ravn, P., Thompson, D. E., Ross, P. D. & Christiansen, C., jul. 2003, I: Bone. 33, 1, s. 150-8 9 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Bone loss occurred after discontinuation of postmenopausal treatment with estrogen, but not with alendronate.

Ravn, P., 2003, I: Evidence-based Obstetrics & Gynecology . 5, 3, s. 147-148

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Visceral fat is more important than peripheral fat for endometrial thickness and bone mass in healthy postmenopausal women

Warming, L., Ravn, P. & Christiansen, C., feb. 2003, I: American Journal of Obstetrics & Gynecology. 188, 2, s. 349-53 5 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2002

Association between pharmacokinetics of oral ibandonate and clinical response in bone mass and bone tumours in women with postmenopausal osteoporosis

Ravn, P., Neugebauer, G. & Christiansen, C., 2002, I: Bone. 30(1), s. 320-4

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Bisphosphonates for prevention of postmenopausal osteoporosis

Ravn, P., 2002, I: Danish Medical Bulletin. 49, 1, s. 1-18. (Review

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Measurement precision and normal range of endometrial thickness in a postmenopausal population by transvaginal ultrasound

Warming, L., Ravn, P., Skouby , S. O. & Christiansen, C., nov. 2002, I: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 20, 5, s. 492-5 4 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2001

Bisphosphonates for prevention of postmenopausal osteoporosis

Ravn, P., 2001, Lægeforeningens forlag.

Publikation: Afhandling › Doktorafhandling

Depression: a major, unrecognized risk factor for osteoporosis?

Cizza, G., Ravn, P., Chrousos, G. P. & Gold, P. W., jul. 2001, I: Trends in Endocrinology and Metabolism. 12, 5, s. 198-203 6 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Prediction of response in bone mass by biochemical markers of bone turnover during antiresorptive therapy for prevention of osteoporosis.

Ravn, P., 2001, Bone markers: biochemical and clinical perspectives. . Eastell, R., Baumann, M., Hoyle, N. R. & Wieczorek, L. (red.). London: Martin Dunitz, s. 167-178

Publikation: Kapitel i bog/rapport/konference-proceeding › Kapitel i bog › Undervisning › peer review

2000

Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal

Ravn, P., Weiss, S. R., Rodriguez-Portales, J. A., McClung, M. R., Wasnich, R. D., Gilchrist, N. L., Sambrook, P., Fogelman, I., Krupa, D., Yates, A. J., Daifotis, A. & Fuleihan, G.E.-H., apr. 2000, I: The Journal of Clinical Endocrinology & Metabolism. 85, 4, s. 1492-1497

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Osteoporosis: Primary prevention.

Ravn, P., 2000, Treatment of metabolic bone disease. Management strategy and drug therapy.. Hosking, D. & Ringe, J. (red.). London: Martin Dunitz, s. 123-141

Publikation: Kapitel i bog/rapport/konference-proceeding › Kapitel i bog › Undervisning › peer review

Relation between body composition and biochemical markers of bone turnover among early postmenopausal women

Hla, M. M., Davis, J. W., Ross, P. D., Yates, J., Wasnich, R. D., Ravn, P., McClung, M. & Hosking, D., 2000, I: Journal of Clinical Densitometry. 3, 4, s. 365-71 7 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1999

Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial

Ravn, P., Bidstrup, M., Wasnich, R. D., Davis, J. W., McClung, M. R., Balske, A., Coupland, C., Sahota, O., Kaur, A., Daley, M. & Cizza, G., 21. dec. 1999, I: Annals of Internal Medicine. 131, 12, s. 935-42 8 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group

Ravn, P., Clemmesen, B. & Christiansen, C., mar. 1999, I: Bone. 24, 3, s. 237-44 8 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Bone Densitometry: A New, Highly Responsive Region of Interest in the Distal Forearm to Monitor the Effect of Osteoporosis Treatment

Ravn, P., Alexandersen, P. & Møllgaard, A., 1999, I: Osteoporosis International. 9, 4, s. 277-283

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women

Ravn, P., Cizza, G., Bjarnason, N. H., Thompson, D., Daley, M., Wasnich, R. D., McClung, M., Hosking, D., Yates, A. J. & Christiansen, C., sep. 1999, I: Journal of Bone and Mineral Research. 14, 9, s. 1622-1627

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study

Ravn, P., Hosking, D., Thompson, D., Cizza, G., Wasnich, R. D., McClung, M., Yates, A. J., Bjarnason, N. H. & Christiansen, C., jul. 1999, I: The Journal of Clinical Endocrinology & Metabolism. 84, 7, s. 2363-2368

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1998

Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Alendronate Osteoporosis Prevention Study Group

McClung, M., Clemmesen, B., Daifotis, A., Gilchrist, N. L., Eisman, J., Weinstein, R. S., Fuleihan G el-H, Reda, C., Yates, A. J. & Ravn, P., 15. feb. 1998, I: Annals of Internal Medicine. 128, 4, s. 253-61 9 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment: prediction of bone mass changes during treatment

Ravn, P., Christensen, J. O., Baumann, M. & Clemmesen, B., maj 1998, I: Bone. 22, 5, s. 559-64 6 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides

Christgau, S., Rosenquist, C., Alexandersen, P., Bjarnason, N. H., Ravn, P., Fledelius, C., Herling, C., Qvist, P. & Christiansen, C., nov. 1998, I: Clinical Chemistry. 44, 11, s. 2290-300 11 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Evidence that increased calcium intake does not prevent early postmenopausal bone loss

Hosking, D. J., Ross, P. D., Thompson, D. E., Wasnich, R. D., McClung, M., Bjarnason, N. H., Ravn, P., Cizza, G., Daley, M. & Yates, A. J., 26. nov. 1998, I: Clinical Therapeutics. 20, 5, s. 933-44 12 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

Hosking, D., Chilvers, C. E. D., Christiansen, C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., Yates, A. J. & Early Postmenopausal Intervention Cohort Study Group, 19. feb. 1998, I: The New England Journal of Medicine. 338, 8, s. 485-492

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Tooth counts do not predict bone mineral density in early postmenopausal Caucasian women. EPIC study group

Earnshaw, S. A., Keating, N., Hosking, D. J., Chilvers, C. E., Ravn, P., McClung, M. & Wasnich, R. D., jun. 1998, I: International Journal of Epidemiology. 27, 3, s. 479-83 5 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Type I collagen C-Telopeptide degradation products as bone resorption markers.

Pedersen, B., Ravn, P. & Bonde, M., 1998, I: Journal of Clinical Ligand Assay. 21, s. 118-127

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1997

1996

A multicenter study of the influence of fat and lean mass on bone mineral content: evidence for differences in their relative influence at major fracture sites. Early Postmenopausal Intervention Cohort (EPIC) Study Group

Hla, M. M., Davis, J. W., Ross, P. D., Wasnich, R. D., Yates, A. J., Ravn, P., Hosking, D. J. & McClung, M. R., sep. 1996, I: The American Journal of Clinical Nutrition. 64, 3, s. 354-60 7 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Body size accounts for most differences in bone density between Asian and Caucasian women. The EPIC (Early Postmenopausal Interventional Cohort) Study Group

Ross, P. D., He, Y., Yates, A. J., Coupland, C., Ravn, P., McClung, M., Thompson, D. & Wasnich, R. D., nov. 1996, I: Calcified Tissue International. 59, 5, s. 339-43 5 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Bone mineral density in immigrants from southern China to Denmark. A cross-sectional study

Ravn, P., Wang, S., Overgaard, K., Hassager, C. & Christiansen, C., feb. 1996, I: European Journal of Endocrinology. 134, 2, s. 163-7 5 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Comparison of bone densitometry of the phalanges, distal forearm and axial skeleton in early postmenopausal women participating in the EPIC Study

Ravn, P., Overgaard, K., Huang, C., Ross, P. D., Green, D. & McClung, M., 1996, I: Osteoporosis International. 6, 4, s. 308-13 6 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

High bone turnover is associated with low bone mass in both pre- and postmenopausal women

Ravn, P., Fledelius, C., Rosenquist, C., Overgaard, K. & Christiansen, C., sep. 1996, I: Bone. 19, 3, s. 291-8 8 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study

Ravn, P., Clemmesen, B., Riis, B. J. & Christiansen, C., nov. 1996, I: Bone. 19, 5, s. 527-33 7 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1995

Early postmenopausal diminution of forearm and spinal bone mineral density: a cross-sectional study

Bjarnason, K., Hassager, C., Ravn, P. & Christiansen, C., jan. 1995, I: Osteoporosis International. 5, 1, s. 35-8 4 s.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Pernille Ravn

Publikationer

Søgeresultater